Peer Review History: Role of Angiotensin-converting Enzyme Inhibitors (ACEI)/Angiotensin Receptor Blockers (ARBs) and Hydrocortisone in COVID-19 Patients Admitted to the Intensive Care Unit

Editor(s):

(1) Dr. Paola Angelini, University of Perugia, Perugia, Italy.

(2) Dr. Jongwha Chang, Texas Woman’s University, College of Business, USA.

Reviewers:

(1)  Shan Sasidharan, India.

(2) Azza Moustafa Fahmy, Theodor Bilharz Research Institute, Egypt.

(3) Ferry Fadzlul Rahman, Universitas Muhammadiyah Kalimantan Timur, Indonesia.

(4) Mohammad Manjur Shah, Yusuf Maitama Sule University, Nigeria.

(5) Samaneh Alinejad Mofrad, Neyshabur University of Medical Sciences, Iran.

Additional Reviewers:

 

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8/10
Average Peer review marks at publication stage: 9.75/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Shan Sasidharan, India) | File 1 | NA


Stage 2 | Peer review report_2 (Azza Moustafa Fahmy, Egypt) | File 1 | File 2


Stage 2 | Peer review report_3 (Ferry Fadzlul Rahman, Indonesia) | File 1 | File 2


Stage 2 | Peer review report_4 (Mohammad Manjur Shah, Nigeria) | File 1 | NA


Stage 2 | Peer review report_5 (Samaneh Alinejad Mofrad, Iran) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


 

Posted in Review History.